Elicio Therapeutics (ELTX) Cash From Investing

Annual CFI

-$32.00 K
+$622.00 K+95.11%

December 31, 2023


Summary


Performance

ELTX Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherELTXcash flowmetrics:

Quarterly CFI

$0.00
+$42.00 K+100.00%

September 30, 2024


Summary


Performance

ELTX Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherELTXcash flowmetrics:

TTM CFI

-$39.00 K
+$45.00 K+53.57%

September 30, 2024


Summary


Performance

ELTX TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherELTXcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

ELTX Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+95.1%+100.0%-21.9%
3 y3 years+84.0%+100.0%-129.4%
5 y5 years+93.5%+100.0%-129.4%

ELTX Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+95.1%-100.0%+100.0%-400.0%+53.6%
5 y5-yearat high+95.1%-100.0%+100.0%-400.0%+53.6%
alltimeall timeat high+95.1%-100.0%+100.0%-400.0%+53.6%

Elicio Therapeutics Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
$0.00(-100.0%)
-$39.00 K(-53.6%)
Jun 2024
-
-$42.00 K(-1500.0%)
-$84.00 K(+600.0%)
Mar 2024
-
$3000.00(>+9900.0%)
-$12.00 K(-62.5%)
Dec 2023
-$32.00 K
$0.00(-100.0%)
-$32.00 K(0.0%)
Sep 2023
-
-$45.00 K(-250.0%)
-$32.00 K(-346.2%)
Jun 2023
-
$30.00 K(-276.5%)
$13.00 K(-176.5%)
DateAnnualQuarterlyTTM
Mar 2023
-
-$17.00 K(-77.6%)
-$17.00 K(-77.6%)
Dec 2022
-$654.00 K(+24.5%)
-
-
Dec 2021
-$525.40 K(+162.8%)
-
-
Mar 2021
-
-$75.90 K(+17.1%)
-$75.90 K(+17.1%)
Dec 2020
-$199.90 K(-59.1%)
-
-
Mar 2020
-
-$64.80 K
-$64.80 K
Dec 2019
-$489.10 K
-
-

FAQ

  • What is Elicio Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Elicio Therapeutics?
  • What is Elicio Therapeutics annual CFI year-on-year change?
  • What is Elicio Therapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Elicio Therapeutics?
  • What is Elicio Therapeutics quarterly CFI year-on-year change?
  • What is Elicio Therapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Elicio Therapeutics?
  • What is Elicio Therapeutics TTM CFI year-on-year change?

What is Elicio Therapeutics annual cash flow from investing activities?

The current annual CFI of ELTX is -$32.00 K

What is the all time high annual CFI for Elicio Therapeutics?

Elicio Therapeutics all-time high annual cash flow from investing activities is -$32.00 K

What is Elicio Therapeutics annual CFI year-on-year change?

Over the past year, ELTX annual cash flow from investing activities has changed by +$622.00 K (+95.11%)

What is Elicio Therapeutics quarterly cash flow from investing activities?

The current quarterly CFI of ELTX is $0.00

What is the all time high quarterly CFI for Elicio Therapeutics?

Elicio Therapeutics all-time high quarterly cash flow from investing activities is $30.00 K

What is Elicio Therapeutics quarterly CFI year-on-year change?

Over the past year, ELTX quarterly cash flow from investing activities has changed by +$45.00 K (+100.00%)

What is Elicio Therapeutics TTM cash flow from investing activities?

The current TTM CFI of ELTX is -$39.00 K

What is the all time high TTM CFI for Elicio Therapeutics?

Elicio Therapeutics all-time high TTM cash flow from investing activities is $13.00 K

What is Elicio Therapeutics TTM CFI year-on-year change?

Over the past year, ELTX TTM cash flow from investing activities has changed by -$7000.00 (-21.88%)